STRIDE INC (LRN) Stock Fundamental Analysis

NYSE:LRN • US86333M1080

84.89 USD
+0.44 (+0.52%)
At close: Feb 13, 2026
84.89 USD
0 (0%)
After Hours: 2/13/2026, 8:22:09 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LRN. LRN was compared to 75 industry peers in the Diversified Consumer Services industry. LRN gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on LRN. This makes LRN very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year LRN was profitable.
  • In the past year LRN had a positive cash flow from operations.
  • LRN had positive earnings in each of the past 5 years.
  • Each year in the past 5 years LRN had a positive operating cash flow.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • The Return On Assets of LRN (13.83%) is better than 88.00% of its industry peers.
  • With an excellent Return On Equity value of 20.61%, LRN belongs to the best of the industry, outperforming 85.33% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 16.82%, LRN belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for LRN is in line with the industry average of 10.20%.
  • The last Return On Invested Capital (16.82%) for LRN is above the 3 year average (11.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.83%
ROE 20.61%
ROIC 16.82%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • LRN has a better Profit Margin (12.66%) than 78.67% of its industry peers.
  • In the last couple of years the Profit Margin of LRN has grown nicely.
  • LRN's Operating Margin of 18.38% is fine compared to the rest of the industry. LRN outperforms 80.00% of its industry peers.
  • LRN's Operating Margin has improved in the last couple of years.
  • LRN has a Gross Margin (39.30%) which is in line with its industry peers.
  • LRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.38%
PM (TTM) 12.66%
GM 39.3%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LRN is creating value.
  • Compared to 1 year ago, LRN has more shares outstanding
  • The number of shares outstanding for LRN has been increased compared to 5 years ago.
  • The debt/assets ratio for LRN has been reduced compared to a year ago.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • LRN has an Altman-Z score of 6.02. This indicates that LRN is financially healthy and has little risk of bankruptcy at the moment.
  • LRN's Altman-Z score of 6.02 is amongst the best of the industry. LRN outperforms 93.33% of its industry peers.
  • The Debt to FCF ratio of LRN is 3.02, which is a good value as it means it would take LRN, 3.02 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of LRN (3.02) is better than 78.67% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that LRN is not too dependend on debt financing.
  • LRN has a Debt to Equity ratio (0.31) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.02
Altman-Z 6.02
ROIC/WACC2.15
WACC7.84%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • A Current Ratio of 7.27 indicates that LRN has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 7.27, LRN belongs to the best of the industry, outperforming 97.33% of the companies in the same industry.
  • LRN has a Quick Ratio of 7.19. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 7.19, LRN belongs to the top of the industry, outperforming 97.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.27
Quick Ratio 7.19
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • LRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.03%, which is quite good.
  • The Earnings Per Share has been growing by 58.07% on average over the past years. This is a very strong growth
  • LRN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.86%.
  • LRN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.24% yearly.
EPS 1Y (TTM)16.03%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%23.15%
Revenue 1Y (TTM)14.86%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%7.5%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.94% on average over the next years. This is quite good.
  • LRN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.21% yearly.
EPS Next Y20.97%
EPS Next 2Y13.66%
EPS Next 3Y11.94%
EPS Next 5YN/A
Revenue Next Year6.21%
Revenue Next 2Y5.8%
Revenue Next 3Y5.91%
Revenue Next 5Y4.21%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.21 indicates a correct valuation of LRN.
  • Compared to the rest of the industry, the Price/Earnings ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 78.67% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.97. LRN is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 10.92, the valuation of LRN can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, LRN is valued cheaply inside the industry as 85.33% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 27.96. LRN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.21
Fwd PE 10.92
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LRN indicates a somewhat cheap valuation: LRN is cheaper than 80.00% of the companies listed in the same industry.
  • LRN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LRN is cheaper than 69.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.75
EV/EBITDA 6
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • LRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of LRN may justify a higher PE ratio.
PEG (NY)0.58
PEG (5Y)0.21
EPS Next 2Y13.66%
EPS Next 3Y11.94%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • LRN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STRIDE INC

NYSE:LRN (2/13/2026, 8:22:09 PM)

After market: 84.89 0 (0%)

84.89

+0.44 (+0.52%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)01-27
Earnings (Next)04-27
Inst Owners111.2%
Inst Owner Change-1.1%
Ins Owners3.06%
Ins Owner Change1.07%
Market Cap3.61B
Revenue(TTM)2.52B
Net Income(TTM)318.94M
Analysts82
Price Target131.71 (55.15%)
Short Float %14.64%
Short Ratio4.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.44%
Min EPS beat(2)18.86%
Max EPS beat(2)26.01%
EPS beat(4)2
Avg EPS beat(4)0.71%
Min EPS beat(4)-41.53%
Max EPS beat(4)26.01%
EPS beat(8)6
Avg EPS beat(8)44.91%
EPS beat(12)10
Avg EPS beat(12)45.21%
EPS beat(16)13
Avg EPS beat(16)17.55%
Revenue beat(2)1
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.46%
Max Revenue beat(2)0.16%
Revenue beat(4)3
Avg Revenue beat(4)1.49%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.34%
Revenue beat(8)7
Avg Revenue beat(8)2.32%
Revenue beat(12)10
Avg Revenue beat(12)2.47%
Revenue beat(16)14
Avg Revenue beat(16)2.55%
PT rev (1m)2.24%
PT rev (3m)-23.35%
EPS NQ rev (1m)3.47%
EPS NQ rev (3m)3.47%
EPS NY rev (1m)-4.46%
EPS NY rev (3m)-8.11%
Revenue NQ rev (1m)2.6%
Revenue NQ rev (3m)2.6%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)-0.93%
Valuation
Industry RankSector Rank
PE 12.21
Fwd PE 10.92
P/S 1.48
P/FCF 20.75
P/OCF 15.04
P/B 2.41
P/tB 3.25
EV/EBITDA 6
EPS(TTM)6.95
EY8.19%
EPS(NY)7.78
Fwd EY9.16%
FCF(TTM)4.09
FCFY4.82%
OCF(TTM)5.64
OCFY6.65%
SpS57.44
BVpS35.29
TBVpS26.14
PEG (NY)0.58
PEG (5Y)0.21
Graham Number74.29
Profitability
Industry RankSector Rank
ROA 13.83%
ROE 20.61%
ROCE 22.19%
ROIC 16.82%
ROICexc 24.03%
ROICexgc 33.13%
OM 18.38%
PM (TTM) 12.66%
GM 39.3%
FCFM 7.12%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
ROICexc(3y)20.97%
ROICexc(5y)16.99%
ROICexgc(3y)36.26%
ROICexgc(5y)30.39%
ROCE(3y)15.79%
ROCE(5y)13.55%
ROICexgc growth 3Y30.19%
ROICexgc growth 5Y48.22%
ROICexc growth 3Y36.36%
ROICexc growth 5Y54.51%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
F-Score7
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.02
Debt/EBITDA 0.83
Cap/Depr 57.06%
Cap/Sales 2.7%
Interest Coverage 44.37
Cash Conversion 42.51%
Profit Quality 56.26%
Current Ratio 7.27
Quick Ratio 7.19
Altman-Z 6.02
F-Score7
WACC7.84%
ROIC/WACC2.15
Cap/Depr(3y)56.69%
Cap/Depr(5y)59.43%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.32%
Profit Quality(3y)114.14%
Profit Quality(5y)117.4%
High Growth Momentum
Growth
EPS 1Y (TTM)16.03%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%23.15%
EPS Next Y20.97%
EPS Next 2Y13.66%
EPS Next 3Y11.94%
EPS Next 5YN/A
Revenue 1Y (TTM)14.86%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%7.5%
Revenue Next Year6.21%
Revenue Next 2Y5.8%
Revenue Next 3Y5.91%
Revenue Next 5Y4.21%
EBIT growth 1Y38.43%
EBIT growth 3Y38.88%
EBIT growth 5Y66.8%
EBIT Next Year36%
EBIT Next 3Y15.81%
EBIT Next 5Y18.08%
FCF growth 1Y13.3%
FCF growth 3Y38.85%
FCF growth 5Y60.14%
OCF growth 1Y12.51%
OCF growth 3Y27.9%
OCF growth 5Y40.03%

STRIDE INC / LRN FAQ

What is the ChartMill fundamental rating of STRIDE INC (LRN) stock?

ChartMill assigns a fundamental rating of 7 / 10 to LRN.


What is the valuation status of STRIDE INC (LRN) stock?

ChartMill assigns a valuation rating of 7 / 10 to STRIDE INC (LRN). This can be considered as Undervalued.


How profitable is STRIDE INC (LRN) stock?

STRIDE INC (LRN) has a profitability rating of 8 / 10.


What is the expected EPS growth for STRIDE INC (LRN) stock?

The Earnings per Share (EPS) of STRIDE INC (LRN) is expected to grow by 20.97% in the next year.


Can you provide the dividend sustainability for LRN stock?

The dividend rating of STRIDE INC (LRN) is 0 / 10 and the dividend payout ratio is 0%.